Literature DB >> 19002339

Psoriasis and dyslipidaemia: a population-based study.

Jacob Dreiher1, Dahlia Weitzman, Batya Davidovici, Jonathan Shapiro, Arnon D Cohen.   

Abstract

Previous reports demonstrated an association between psoriasis and the metabolic syndrome. The aim of this study was to elucidate the association between psoriasis and dyslipidaemia. A cross-sectional study was performed utilizing a population-based database. Psoriasis patients were compared with enrollees without psoriasis regarding the prevalence of dyslipidaemia and lipid levels. Comparison of lipid levels was performed on a "low-risk" subset of subjects without diabetes, hypertension and cardiovascular disease. The study included 10,669 psoriasis patients and 22,996 subjects without psoriasis. The prevalence of dyslipidaemia was significantly higher in psoriasis patients (odds ratio (OR) = 1.48, 95% confidence interval (CI) 1.40-1.55). The association remained significant after controlling for confounders (OR = 1.19, 95% CI 1.12-1.26, p < 0.001). In multivariate analysis of the "low-risk" subset, triglyceride levels were higher in psoriasis patients and high-density lipoprotein cholesterol levels were lower. This study supports previous reports of an association between psoriasis and lipid abnormalities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19002339     DOI: 10.2340/00015555-0510

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  21 in total

Review 1.  "Inflammatory skin march" in atopic dermatitis and psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Inflamm Res       Date:  2017-06-15       Impact factor: 4.575

2.  Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.

Authors:  Thorvardur Jon Love; Abrar A Qureshi; Elizabeth Wood Karlson; Joel M Gelfand; Hyon K Choi
Journal:  Arch Dermatol       Date:  2010-12-20

Review 3.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

4.  Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies.

Authors:  Saumya Choudhary; Rachana Patel; Dibyabhaba Pradhan; Ravi Deval; Harpreet Singh; George Thomas; Arun Kumar Jain
Journal:  3 Biotech       Date:  2020-02-07       Impact factor: 2.406

5.  Factors associated with the length of remission of psoriasis vulgaris.

Authors:  Susana Coimbra; Hugo Oliveira; Américo Figueiredo; Petronila Rocha-Pereira; Alice Santos-Silva
Journal:  Clin Drug Investig       Date:  2013-11       Impact factor: 2.859

6.  More Biologic Therapies Expected To Treat Advanced Plaque Psoriasis.

Authors:  Chris Fellner
Journal:  P T       Date:  2016-06

7.  Psoriasis and hypertension severity: results from a case-control study.

Authors:  April W Armstrong; Steven W Lin; Cynthia J Chambers; Mary E Sockolov; David L Chin
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

Review 8.  New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

Authors:  Di Yan; Andrew Blauvelt; Amit K Dey; Rachel S Golpanian; Samuel T Hwang; Nehal N Mehta; Bridget Myers; Zhen-Rui Shi; Gil Yosipovitch; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-04-19       Impact factor: 7.590

9.  Trends in lipid profiles in patients with psoriasis: a population-based analysis.

Authors:  Bharath Manu Akkara Veetil; Eric L Matteson; Hilal Maradit-Kremers; Marian T McEvoy; Cynthia S Crowson
Journal:  BMC Dermatol       Date:  2012-10-30

10.  Associations between cardiovascular risk factors and psoriasis in Iran.

Authors:  Mahmoud Farshchian; Akram Ansar; Mohammadreza Sobhan
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.